Why does my A1c keep climbing while my weight holds steady? In most cases, insulin resistance is worsening inside a body that has not changed size. The scale is a lagging, blunt instrument. It cannot see muscle being replaced by fat, a thyroid slowing down, cortisol running high from untreated sleep apnea or the slow decline in insulin sensitivity that arrives with age and inactivity. Any one of those can push your average blood sugar up while the number on the scale sits still.
We see this pattern constantly in our practice. A patient comes in with a normal BMI and an A1c that has drifted from 5.4 to 5.9 over three years. Their prior doctor told them the weight is fine so there is nothing to do. The truth is the opposite: a stable weight with a rising A1c is often the earliest and most actionable warning the metabolic system will give you.
- A1c measures average blood sugar over roughly three months, so a rising number reflects a metabolic shift, not a bad week.
- Insulin resistance can worsen without weight change, especially when lean mass is being replaced by visceral fat.
- Thyroid drift, sleep apnea, certain medications and perimenopause can all raise A1c independently of body weight.
- A single annual panel misses all of this. Quarterly biomarker tracking catches the drift while it is still easy to reverse.
What A1c actually measures
A1c reflects the average glucose your red blood cells were exposed to over their roughly 120-day lifespan. It is a useful population screening tool and a poor single snapshot. Two people with identical A1c can have very different metabolic realities: one with stable insulin sensitivity and one with rapidly progressing insulin resistance that is being partially compensated by a still-functioning pancreas. The A1c alone cannot tell you which is which. Fasting insulin and a proper lipid panel with ApoB and Lp(a) can.
The five hidden causes
- Sarcopenic obesity, also called normal-weight obesity. Muscle is your largest glucose sink. When lean mass falls and visceral fat rises, insulin sensitivity falls even if total weight is unchanged. This is the most common cause we see in patients over 45 who diet frequently without resistance training.
- Thyroid dysfunction. Hypothyroidism slows glucose metabolism and raises A1c modestly. A thyroid panel in the conventional normal range can still be suboptimal for you, which is why we read free T3 and free T4 alongside TSH and antibodies.
- Sleep apnea and chronic sleep debt. Intermittent hypoxia and sympathetic activation from untreated sleep apnea raise cortisol and glucose. If your A1c is climbing and you snore or wake unrefreshed, this is a test worth ordering.
- Medications. Corticosteroids, some antidepressants, beta blockers and statins can each nudge glucose upward. This is not a reason to stop them, it is a reason to have a clinician reading the interaction.
- Perimenopause and low testosterone. Falling estradiol in women and falling testosterone in men both worsen insulin sensitivity. This is the reason a 48-year-old can eat identically to their 38-year-old self and see an entirely different A1c.
How we work it up
| Test | What it tells you that A1c alone cannot |
|---|---|
| Fasting insulin + HOMA-IR | How hard your pancreas is working to hold the line |
| ApoB and Lp(a) | The atherosclerotic risk A1c never captures |
| hs-CRP | Systemic inflammation driving insulin resistance |
| Full thyroid panel | Subclinical hypothyroidism raising glucose |
| Testosterone and estradiol | Hormonal contribution to insulin resistance |
| Body composition (muscle vs fat) | Whether the weight is stable because muscle is being lost |
This is the Biomarker Audit and it runs every 90 days inside the membership. Not once a year, not when a symptom finally forces a visit. Every ninety days, so the drift is caught while the intervention is still small.
A real objection, named plainly: 'My A1c is only 5.9, that is barely prediabetic, why would I pay $299 a month for that?' Because 5.9 is the point where reversal is still easy and the window is closing. The trial data on intensive lifestyle intervention (the Diabetes Prevention Program) showed a 58 percent reduction in progression to diabetes when the intervention happened early. Waiting until the A1c crosses 6.5 makes that fight much harder. The flat fee covers the physician, the quarterly Biomarker Audit and the clinical protocols. Medication is billed separately by the pharmacy at cost with zero markup, so nothing about the membership pressures us toward prescriptions.
What actually lowers it
We rank interventions by how much they move the number, not by how fashionable they are.
- Resistance training. Adding lean mass is the single highest-leverage move for insulin sensitivity in a stable-weight patient. Two to three sessions per week, progressive overload, no exceptions.
- Protein and fiber structure. Adequate protein (0.54 to 0.73 g/lb) and 30 or more grams of fiber daily blunt post-meal glucose spikes better than any single food elimination.
- Treating the hidden cause. If thyroid, sleep apnea or hormonal decline is driving the drift, fixing that cause moves the A1c in a way diet never will.
- GLP-1 therapy when indicated. For patients whose A1c is climbing despite the above, branded GLP-1 medications (Ozempic, Mounjaro, Wegovy, Zepbound, Wegovy Tablets, Foundayo) improve insulin sensitivity and weight and are chosen by labs and clinical judgment, not by a dose ladder. The flat fee does not change with the dose, so our clinical guidance has no profit motive either way.
We want to be direct about the math. Two-month commitment to start at $598, then $299/month, cancel anytime after. The medicine is a separate charge billed by the pharmacy at cost with zero markup. One flat fee for the doctor, zero markup on the medicine. If you are the kind of person who reads numbers carefully, we want you to read ours exactly the same way.
A stable weight with a rising A1c is often the earliest warning the metabolic system will give you.
Frequently asked questions
Can A1c rise without weight gain?
Yes and it happens more often than patients expect. Insulin resistance can worsen as muscle mass declines and visceral fat rises, even when total weight holds steady. Thyroid dysfunction, untreated sleep apnea, certain medications and hormonal changes in perimenopause or low testosterone can each raise A1c independently of body weight. This is why a stable scale tells you nothing about metabolic direction.
What A1c level is prediabetic?
The ADA defines prediabetes as an A1c between 5.7 and 6.4 percent, with 6.5 percent or above on two separate tests indicating diabetes. But the underlying insulin resistance usually develops years before the number crosses 5.7. A patient with a 5.5 today and a rising trend over three panels is often at greater immediate risk than someone sitting stable at 5.8.
How often should A1c be checked?
Annual screening is the conventional answer for people with normal results. For patients with any cardiometabolic concern, insulin resistance or a rising trend, quarterly monitoring is what we use because A1c reflects a roughly three-month average. Quarterly checks align with the biology and let us catch a trend at the second data point instead of the third or fourth.
Does stress raise A1c?
Chronic stress raises cortisol and cortisol raises blood glucose, so yes, sustained stress can move A1c upward over months. The bigger risk is that stress also disrupts sleep, which independently worsens insulin sensitivity. We treat sleep and stress as metabolic variables, not lifestyle afterthoughts, because the labs show they are neither.
Will losing weight fix my A1c?
Weight loss helps and for patients with insulin resistance and elevated A1c it is often part of the answer. But the composition of the weight matters more than the number of pounds. Losing muscle while losing fat can leave insulin sensitivity unchanged or worse. This is why our protocols pair any weight-loss intervention with resistance training and protein targets and why body composition is part of the audit.
Is metformin still worth taking for prediabetes?
Metformin remains a reasonable, inexpensive option for some patients with prediabetes, particularly those with higher baseline glucose or a strong family history. It is not the only tool and it does not address the muscle loss or hormonal components that often drive the trend. We use it selectively, alongside the same quarterly monitoring, rather than as a default answer.
Do you prescribe GLP-1 medication for a rising A1c?
Yes, when labs and clinical judgment support it. Branded, FDA-approved GLP-1 medications (Ozempic, Mounjaro, Wegovy, Zepbound, Wegovy Tablets and Foundayo) improve insulin sensitivity and are appropriate for some patients with prediabetes or early type 2 diabetes. They are not a first-line move for everyone with a 5.9. The prescription decision comes from the full biomarker panel, not from a BMI threshold.
How much does the membership cost and what does it include?
The Cardiometabolic Optimization Membership is a flat $299 per month. You start with a two-month commitment at $598, then it is month to month, cancel anytime after. The fee covers the clinical relationship, the quarterly Biomarker Audit (ApoB, Lp(a), hs-CRP, HbA1c, lipids, insulin markers and the full hormone and thyroid panel) and the clinical protocols. The medication is billed separately by the pharmacy at cost, with zero markup, no molecule upcharge and no dose-escalation fee. Two separate charges, by design.
Related guides
- Cardiometabolic Optimization: the definitive guide
- What a Biomarker Audit includes
- How GLP-1s work and what happens when they stop
- Direct primary care for cardiometabolic care
External reference: the American Diabetes Association publishes the Standards of Care in Diabetes, updated annually and used as the clinical baseline for the thresholds above.
References
- Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). 2022. pubmed.ncbi.nlm.nih.gov/35658024/
- Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). 2021. pubmed.ncbi.nlm.nih.gov/33567185/